Cargando…

MGMT-Methylated Alleles Are Distributed Heterogeneously Within Glioma Samples Irrespective of IDH Status and Chromosome 10q Deletion

Several molecular markers drive diagnostic classification, prognostic stratification, and/or prediction of response to therapy in patients with gliomas. Among them, IDH gene mutations are valuable markers for defining subtypes and are strongly associated with epigenetic silencing of the methylguanin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontana, Laura, Tabano, Silvia, Bonaparte, Eleonora, Marfia, Giovanni, Pesenti, Chiara, Falcone, Rossella, Augello, Claudia, Carlessi, Nicole, Silipigni, Rosamaria, Guerneri, Silvana, Campanella, Rolando, Caroli, Manuela, Maria Sirchia, Silvia, Bosari, Silvano, Miozzo, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409217/ https://www.ncbi.nlm.nih.gov/pubmed/27346749 http://dx.doi.org/10.1093/jnen/nlw052

Ejemplares similares

Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status
por: Pesenti, Chiara, et al.
Publicado: (2017)

Beckwith–Wiedemann syndrome prenatal diagnosis by methylation analysis in chorionic villi
por: Paganini, Leda, et al.
Publicado: (2015)

Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry
por: Bonaparte, Eleonora, et al.
Publicado: (2018)

The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity
por: Pesenti, Chiara, et al.
Publicado: (2019)

Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma
por: Marfia, Giovanni, et al.
Publicado: (2016)

Clinical and Molecular Diagnosis of Beckwith-Wiedemann Syndrome with Single- or Multi-Locus Imprinting Disturbance
por: Fontana, Laura, et al.
Publicado: (2021)

Extensive Placental Methylation Profiling in Normal Pregnancies
por: Rondinone, Ornella, et al.
Publicado: (2021)

Correction: Rondinone et al. Extensive Placental Methylation Profiling in Normal Pregnancies. Int. J. Mol. Sci. 2021, 22, 2136
por: Rondinone, Ornella, et al.
Publicado: (2022)

Sequence variants identification at the KCNQ1OT1:TSS differentially Methylated region in isolated omphalocele cases
por: Bedeschi, Maria Francesca, et al.
Publicado: (2017)

Profound alterations of the chromatin architecture at chromosome 11p15.5 in cells from Beckwith-Wiedemann and Silver-Russell syndromes patients
por: Rovina, Davide, et al.
Publicado: (2020)

A HS6ST2 gene variant associated with X‐linked intellectual disability and severe myopia in two male twins
por: Paganini, Leda, et al.
Publicado: (2018)

Constitutive BRCA1 Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer
por: Azzollini, Jacopo, et al.
Publicado: (2019)

Assessment of pregnancy dietary intake and association with maternal and neonatal outcomes
por: Costanza, Jole, et al.
Publicado: (2021)

Analysis of BRCA1 and RAD51C Promoter Methylation in Italian Families at High-Risk of Breast and Ovarian Cancer
por: Tabano, Silvia, et al.
Publicado: (2020)

Quantitative DNA methylation analysis improves epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome
por: Calvello, Mariarosaria, et al.
Publicado: (2013)

Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy
por: Guarnaccia, Laura, et al.
Publicado: (2018)

Fragile X syndrome: a review of clinical and molecular diagnoses
por: Ciaccio, Claudia, et al.
Publicado: (2017)

Cohesin Mutations Induce Chromatin Conformation Perturbation of the H19/IGF2 Imprinted Region and Gene Expression Dysregulation in Cornelia de Lange Syndrome Cell Lines
por: Pileggi, Silvana, et al.
Publicado: (2021)

Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status
por: Venneker, Sanne, et al.
Publicado: (2019)

Misbehaviour of XIST RNA in Breast Cancer Cells
por: Sirchia, Silvia M., et al.
Publicado: (2009)

IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
por: Yang, Pei, et al.
Publicado: (2015)

Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
por: Radke, Josefine, et al.
Publicado: (2019)

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation
por: Marchi, Francesco, et al.
Publicado: (2020)

HOXA genes cluster: clinical implications of the smallest deletion
por: Pezzani, Lidia, et al.
Publicado: (2015)

Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms
por: Salsano, Ettore, et al.
Publicado: (2012)

Beckwith–Wiedemann and IMAGe syndromes: two very different diseases caused by mutations on the same gene
por: Milani, Donatella, et al.
Publicado: (2014)

(Epi)genetic profiling of extraembryonic and postnatal tissues from female monozygotic twins discordant for Beckwith–Wiedemann syndrome
por: Fontana, Laura, et al.
Publicado: (2020)

Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status()
por: Myung, Jae Kyung, et al.
Publicado: (2014)

XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
por: Le, Nguyen Quoc Khanh, et al.
Publicado: (2020)

Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
por: Chai, Ruichao, et al.
Publicado: (2021)

Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies
por: Azzollini, Jacopo, et al.
Publicado: (2017)

MassARRAY-based simultaneous detection of hotspot somatic mutations and recurrent fusion genes in papillary thyroid carcinoma: the PTC-MA assay
por: Pesenti, Chiara, et al.
Publicado: (2017)

Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
por: Mareike, Müller, et al.
Publicado: (2021)

Immunohistochemical Expression of PD-L1 and IDH1 with Detection of MGMT Promoter Methylation in Astrocytoma
por: Hareedy, Amal Ahmed, et al.
Publicado: (2022)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018)

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
por: Combs, Stephanie E, et al.
Publicado: (2011)

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma
por: Schiffgens, Salveena, et al.
Publicado: (2016)

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation
por: Incekara, Fatih, et al.
Publicado: (2020)

Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
por: Wang, Ke, et al.
Publicado: (2021)

Sensitivity to PRIMA-1(MET) is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status
por: Patyka, Mariia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_23s1150d6uhblo7917uq86j36d